Jason Harvison - Feb 28, 2023 Form 4 Insider Report for Elevate Credit, Inc. (ELVT)

Role: President and CEO, Director
Signature: /s/Nelda Bruce, as attorney-in-fact
Stock symbol: ELVT
Transactions as of: Feb 28, 2023
Transactions value $: -$1,061,474
Form type: 4
Date filed: 3/2/2023, 04:57 PM
Previous filing: Feb 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELVT	Common Stock	Disposed to Issuer	-$1.06M	-568K	-100%	$1.87	0	Feb 28, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVT	Restricted Stock Unit (RSU)	Disposed to Issuer		-27.8K	-100%		0	Feb 28, 2023	Common Stock	27.8K		Direct	F2
transaction	ELVT	Restricted Stock Unit (RSU)	Disposed to Issuer		-66.3K	-100%		0	Feb 28, 2023	Common Stock	66.3K		Direct	F3
transaction	ELVT	Restricted Stock Unit (RSU)	Disposed to Issuer		-122K	-100%		0	Feb 28, 2023	Common Stock	122K		Direct	F4
transaction	ELVT	Restricted Stock Unit (RSU)	Disposed to Issuer		-508K	-100%		0	Feb 28, 2023	Common Stock	508K		Direct	F5
transaction	ELVT	Restricted Stock Unit (RSU)	Disposed to Issuer		-550K	-100%		0	Feb 28, 2023	Common Stock	550K		Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jason Harvison is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Pursuant to the Agreement and Plan of Merger, dated as of November 16, 2022 (the "Merger Agreement"), by and among Elevate Credit, Inc., ("the Company), PCAM Acquisition Corp ("Parent") and PCAM Merger Sub Corp ("Merger Sub"), the Merger Sub merged with and into the Company ("the Merger") with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of the Company's Common Stock, par value $0.0004 per share, was cancelled and converted into the right to receive $1.87 in cash. Pursuant to the Rollover Agreement dated as of February 27, 2023 (the "Rollover Agreement"), among the reporting person and Parent, the reporting person agreed to contribute 156,355 shares to Parent (the "Rollover") in exchange for shares of common stock of the Parent, effective as of the effective time of the Merger. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.
F2	Pursuant to the Rollover Agreement, among the reporting person and Parent, each outstanding RSU in this grant was cancelled and converted into a right to receive on the vesting date originally applicable to such RSU, subject to the terms applicable to such RSU, shares of Parent Company. The reporting person was granted 111,111 RSUs on August 15, 2019, vesting in four annual installments, beginning on the first anniversary of the grant date and converting into common stock on a one-for-one basis. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.
F3	Pursuant to the Rollover Agreement, among the reporting person and Parent, each outstanding RSU in this grant was cancelled and converted into a right to receive on the vesting date originally applicable to such RSU, subject to the terms applicable to such RSU, shares of Parent Company. The reporting person was granted 265,251 RSUs on November 21, 2019, vesting in four annual installments, beginning on the first anniversary of the grant date and converting into common stock on a one-for-one basis. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.
F4	Pursuant to the Rollover Agreement, among the reporting person and Parent, each outstanding RSU in this grant was cancelled and converted into a right to receive on the vesting date originally applicable to such RSU, subject to the terms applicable to such RSU, shares of Parent Company. The reporting person was granted 244,444 RSUs on March 15, 2020, vesting in four annual installments, beginning on the first anniversary of the grant date and converting into common stock on a one-for-one basis. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.
F5	Pursuant to the Rollover Agreement, among the reporting person and Parent, each outstanding RSU in this grant was cancelled and converted into a right to receive on the vesting date originally applicable to such RSU, subject to the terms applicable to such RSU, shares of Parent Company. The reporting person was granted 676,923 RSUs on March 15, 2021, vesting in four annual installments, beginning on the first anniversary of the grant date and converting into common stock on a one-for-one basis. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.
F6	Pursuant to the Rollover Agreement, among the reporting person and Parent, each outstanding RSU in this grant was cancelled and converted into a right to receive on the vesting date originally applicable to such RSU, subject to the terms applicable to such RSU, shares of Parent Company. The reporting person was granted 550,000 RSUs on March 15, 2022, vesting in three annual installments, beginning on the first anniversary of the grant date and converting into common stock on a one-for-one basis. For purposes of the Rollover, the reporting person's shares were valued at $1.87 per share.